Thus, AKT3 expression in AML samples is apparently following a counterintuitive pattern with the M4/M5 myelomonocytic/monocytic leukemia samples exhibiting the highest levels of AKT3 expression, as opposed to what happens in normal differentiation. This evidence concerns the gene AKT3 and monocytic leukemia.